Brief: SSY Group Obtains NMPA Approval For Oseltamivir Phosphate Capsules (30Mg, 45Mg And 75Mg), Others
11/05/2026 02:40
May 11 (Reuters) - SSY Group Ltd 2005.HK: OBTAINS NMPA APPROVAL FOR OSELTAMIVIR PHOSPHATE CAPSULES (30MG, 45MG AND 75MG) OBTAINS NMPA APPROVAL FOR DROTAVERINE HYDROCHLORIDE TABLETS (40MG) OBTAINS NMPA APPROVAL FOR METOCLOPRAMIDE TABLETS Further company coverage: 2005.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on SSY
See all newsBrief: SSY Group Receives NMPA China Approval For Sodium Cromoglicate Eye Drops 2%
Brief: SSY Group Obtains NMPA Approval For Nimodipine Oral Solution
Brief: SSY Group Appoints Wu Heng Yao As Executive Director
Brief: SSY Group Says Ziprasidone Mesilate Receives Registration Approval In China
Hong Kong's SSY Group H1 profit rises on infusion solutions growth